New scan could slash unnecessary prostate biopsies
NCT ID NCT06305390
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining two types of scans (PET and MRI) before a prostate biopsy can more accurately find serious prostate cancers while avoiding unnecessary biopsies for low-risk cancers. About 167 men with suspected prostate cancer will receive the combined scan, and results will be compared to standard biopsy. The goal is to reduce false negatives and overdiagnosis of harmless cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL SUSPICION OF PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
U.O. of Nuclear Medicine, ,Ospedale San Raffaele
RECRUITINGMilan, Milano, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which biopsy route catches more aggressive prostate cancers?
- Double-Team biopsy could catch more dangerous prostate cancers
- AI could spare thousands from unnecessary prostate biopsies
- New blood test could spot dangerous prostate cancer without a biopsy
- New scan could help men with Low-Risk prostate cancer avoid unnecessary biopsies